Changlei Bao
Impact in
-
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
- Surgery 5
- Cardiovascular, Neuropeptides, and Oxidative Stress Research 4
- Hydrogen's biological and therapeutic effects 1
-
- Viral Infectious Diseases and Gene Expression in Insects 1
- Co-authors
- Shuxin Liang (7 shared papers)Haiyang Tang (12 shared papers)Ang Luo (7 shared papers)Ying Guo (1 shared paper)Jian Wang (5 shared papers)Yong Zhang (1 shared paper)Fengyu Wang (1 shared paper)Ying Han (8 shared papers)
- Journals
- Signal Transduction and Targeted Therapy (2 papers)Oxidative Medicine and Cellular Longevity (2 papers)Frontiers in Pharmacology (2 papers)Journal of Proteome Research (1 paper)Hypertension (1 paper)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Changlei Bao
16 papers receiving 257 citations
Peers
Comparison fields: 5 of 68
- Infectious Diseases 41
- Cardiology and Cardiovascular Medicine 39
- Sensory Systems 8
- Cancer Research 24
- Epidemiology 51
Countries citing papers authored by Changlei Bao
This map shows the geographic impact of Changlei Bao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changlei Bao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changlei Bao more than expected).
Fields of papers citing papers by Changlei Bao
This network shows the impact of papers produced by Changlei Bao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changlei Bao. The network helps show where Changlei Bao may publish in the future.
Co-authors
The 25 scholars most cited alongside Changlei Bao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 52 | |
| 2 | 2023 | 50 | |
| 3 | 2023 | 30 | |
| 4 | 2019 | 24 | |
| 5 | 2016 | 22 | |
| 6 | 2022 | 18 | |
| 7 | 2022 | 16 | |
| 8 | 2021 | 10 | |
| 9 | 2021 | 10 | |
| 10 | 2022 | 8 | |
| 11 | 2021 | 8 | |
| 12 | 2022 | 4 | |
| 13 | 2023 | 3 | |
| 14 | 2024 | 2 | |
| 15 | Classical swine fever virus entry into ST cells by clathrin-mediated endocytosis pathway. | 2017 | 1 |
| 16 | 2022 | 1 |
About Changlei Bao
Changlei Bao is a scholar working on Surgery, Molecular Biology, Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Agronomy and Crop Science, having authored 16 papers that have together received 259 indexed citations. Recurring topics across this work include Pulmonary Hypertension Research and Treatments (4 papers), Cardiovascular, Neuropeptides, and Oxidative Stress Research (4 papers), Renin-Angiotensin System Studies (2 papers), Animal Disease Management and Epidemiology (2 papers), Hormonal Regulation and Hypertension (2 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (1 paper), Hydrogen's biological and therapeutic effects (1 paper) and Viral Infectious Diseases and Gene Expression in Insects (1 paper). The work is most often cited by research in Infectious Diseases (41 citations), Cardiology and Cardiovascular Medicine (39 citations), Sensory Systems (8 citations), Cancer Research (24 citations) and Epidemiology (51 citations). Changlei Bao has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Shuxin Liang, Haiyang Tang, Ang Luo, Ying Guo, Jian Wang, Yong Zhang, Fengyu Wang, Ying Han, Jing Han and Yanming Zhang. Their work appears in journals such as Signal Transduction and Targeted Therapy, Oxidative Medicine and Cellular Longevity, Frontiers in Pharmacology, Journal of Proteome Research and Hypertension.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.